Rethinking Endothelial Dysfunction as a Crucial Target in Fighting Heart Failure

[1]  S. Carlson,et al.  The Physical Activity Guidelines for Americans , 2018, JAMA.

[2]  Qishan Chen,et al.  Reactive oxygen species: key regulators in vascular health and diseases , 2018, British journal of pharmacology.

[3]  Francesca N. Delling,et al.  Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association , 2018, Circulation.

[4]  Akshay S. Desai,et al.  Racial Differences in Characteristics and Outcomes of Patients With Heart Failure and Preserved Ejection Fraction in the Treatment of Preserved Cardiac Function Heart Failure Trial , 2018, Circulation. Heart failure.

[5]  H. Tasaki,et al.  Heart failure with preserved vs reduced ejection fraction following cardiac rehabilitation: impact of endothelial function , 2018, Heart and Vessels.

[6]  D. Umpierre,et al.  Endothelial Alterations in Heart Failure—Mechanisms and Molecular Basis , 2018 .

[7]  K. Das,et al.  Decreased EDHF‐mediated relaxation is a major mechanism in endothelial dysfunction in resistance arteries in aged mice on prolonged high‐fat sucrose diet , 2017, Physiological reports.

[8]  Gerasimos S Filippatos,et al.  2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. , 2017, Journal of the American College of Cardiology.

[9]  C. Vrints,et al.  Targeting Endothelial Function to Treat Heart Failure with Preserved Ejection Fraction: The Promise of Exercise Training , 2017, Oxidative medicine and cellular longevity.

[10]  B. Pieske,et al.  Reliability of peripheral arterial tonometry in patients with heart failure, diabetic nephropathy and arterial hypertension , 2017, Vascular medicine.

[11]  Alan W. Stitt,et al.  Endothelial Progenitors: A Consensus Statement on Nomenclature , 2017, Stem cells translational medicine.

[12]  L. Shaw,et al.  Progenitor Cells and Clinical Outcomes in Patients With Heart Failure , 2017, Circulation. Heart failure.

[13]  N. Smart,et al.  Aerobic Training Intensity for Improved Endothelial Function in Heart Failure Patients: A Systematic Review and Meta-Analysis , 2017, Cardiology research and practice.

[14]  H. Husi,et al.  CVD and Oxidative Stress , 2017, Journal of clinical medicine.

[15]  R. Hendel,et al.  Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy: POSEIDON-DCM Trial. , 2017, Journal of the American College of Cardiology.

[16]  J. Hare,et al.  Nitric Oxide Regulation of Cardiovascular Physiology and Pathophysiology , 2017 .

[17]  P. Ponikowski,et al.  [2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure]. , 2016, Kardiologia polska.

[18]  Yabing Chen,et al.  Redox signaling in cardiovascular pathophysiology: A focus on hydrogen peroxide and vascular smooth muscle cells , 2016, Redox biology.

[19]  Volkmar Falk,et al.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.

[20]  J. Sowers,et al.  Endothelium-Derived Hyperpolarizing Factors: A Potential Therapeutic Target for Vascular Dysfunction in Obesity and Insulin Resistance , 2016, Diabetes.

[21]  L. Lerman,et al.  Coronary endothelial function testing provides superior discrimination compared with standard clinical risk scoring in prediction of cardiovascular events , 2016, Coronary artery disease.

[22]  G. Schuler,et al.  Chronic heart failure and aging – effects of exercise training on endothelial function and mechanisms of endothelial regeneration: Results from the Leipzig Exercise Intervention in Chronic heart failure and Aging (LEICA) study , 2016, European journal of preventive cardiology.

[23]  A. Quyyumi,et al.  Nitric Oxide Contributes to Vasomotor Tone in Hypertensive African Americans Treated With Nebivolol and Metoprolol , 2016, Journal of clinical hypertension.

[24]  R. Allan,et al.  A Comparison of Measures of Endothelial Function in Patients with Peripheral Arterial Disease and Age and Gender Matched Controls , 2016, International journal of vascular medicine.

[25]  L. Lund,et al.  Microvascular endothelial dysfunction in heart failure with preserved ejection fraction , 2016, Heart.

[26]  S. Nesterov,et al.  Cardiac rehabilitation improves coronary endothelial function in patients with heart failure due to dilated cardiomyopathy: A positron emission tomography study , 2016, European journal of preventive cardiology.

[27]  N. Sattar,et al.  Prognostic significance of infarct core pathology revealed by quantitative non-contrast in comparison with contrast cardiac magnetic resonance imaging in reperfused ST-elevation myocardial infarction survivors , 2015, European heart journal.

[28]  N. Bouabdallaoui,et al.  Vascular and Microvascular Endothelial Function in Heart Failure With Preserved Ejection Fraction. , 2016, Journal of cardiac failure.

[29]  K. Sakamoto,et al.  Prognostic Significance of Peripheral Microvascular Endothelial Dysfunction in Heart Failure With Reduced Left Ventricular Ejection Fraction. , 2015, Circulation journal : official journal of the Japanese Circulation Society.

[30]  J. Majerník,et al.  Effect of Ivabradine on Endothelial Function in Patients with Stable Angina Pectoris: Assessment with the Endo-PAT 2000 Device , 2015, Advances in Therapy.

[31]  M. Haykowsky,et al.  High-intensity interval training vs. moderate-intensity continuous exercise training in heart failure with preserved ejection fraction: a pilot study. , 2015, Journal of applied physiology.

[32]  H. Langberg,et al.  Effect of moderate- versus high-intensity exercise on vascular function, biomarkers and quality of life in heart transplant recipients: A randomized, crossover trial. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[33]  B. Hurwitz,et al.  Allogeneic Mesenchymal Stem Cells Restore Endothelial Function in Heart Failure by Stimulating Endothelial Progenitor Cells , 2015, EBioMedicine.

[34]  A. Papavassiliou,et al.  Atorvastatin treatment improves endothelial function through endothelial progenitor cells mobilization in ischemic heart failure patients. , 2015, Atherosclerosis.

[35]  A. Quyyumi,et al.  Contribution of endothelium-derived hyperpolarizing factor to exercise-induced vasodilation in health and hypercholesterolemia , 2015, Vascular medicine.

[36]  S. Popov,et al.  Exercise and NO production: relevance and implications in the cardiopulmonary system , 2015, Front. Cell Dev. Biol..

[37]  L. Ghiadoni,et al.  Endothelial function testing and cardiovascular disease: focus on peripheral arterial tonometry , 2014, Vascular health and risk management.

[38]  K. Poh,et al.  Endothelial progenitor cells in cardiovascular diseases. , 2014, World journal of stem cells.

[39]  Sanjiv J Shah,et al.  Spironolactone for heart failure with preserved ejection fraction. , 2014, The New England journal of medicine.

[40]  Santiago Lamas,et al.  Hydrogen peroxide signaling in vascular endothelial cells , 2014, Redox biology.

[41]  J. Baugh,et al.  Role of inflammation in the pathogenesis of heart failure with preserved ejection fraction and its potential as a therapeutic target , 2014, Heart Failure Reviews.

[42]  Sanjiv J. Shah,et al.  The Emerging Epidemic of Heart Failure with Preserved Ejection Fraction , 2013, Current Heart Failure Reports.

[43]  W. Hundley,et al.  Effect of endurance exercise training on endothelial function and arterial stiffness in older patients with heart failure and preserved ejection fraction: a randomized, controlled, single-blind trial. , 2013, Journal of the American College of Cardiology.

[44]  J. Hare,et al.  Nitroso-redox imbalance affects cardiac structure and function. , 2013, Journal of the American College of Cardiology.

[45]  S. Umemura,et al.  Incremental prognostic significance of peripheral endothelial dysfunction in patients with heart failure with normal left ventricular ejection fraction. , 2012, Journal of the American College of Cardiology.

[46]  Arshed A Quyyumi,et al.  Endothelial dysfunction, arterial stiffness, and heart failure. , 2012, Journal of the American College of Cardiology.

[47]  Z. Kassiri,et al.  Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease , 2012, Fibrogenesis & tissue repair.

[48]  Takeshi Kimura,et al.  Effects of machine-assisted cycling on exercise capacity and endothelial function in elderly patients with heart failure. , 2012, Circulation journal : official journal of the Japanese Circulation Society.

[49]  Francesco Faita,et al.  Assessment of flow-mediated dilation reproducibility: a nationwide multicenter study , 2012, Journal of hypertension.

[50]  J. Hare,et al.  Regulation of cardiovascular cellular processes by S-nitrosylation. , 2012, Biochimica et biophysica acta.

[51]  S. T. Rahman,et al.  Vascular Effects of Nebivolol Added to Hydrochlorothiazide in African Americans With Hypertension and Echocardiographic Evidence of Diastolic Dysfunction , 2012, Journal of cardiovascular pharmacology and therapeutics.

[52]  G. Stouffer,et al.  Relation between digital peripheral arterial tonometry and brachial artery ultrasound measures of vascular function in patients with coronary artery disease and in healthy volunteers. , 2012, The American journal of cardiology.

[53]  J. Stamler,et al.  Dynamic denitrosylation via S-nitrosoglutathione reductase regulates cardiovascular function , 2012, Proceedings of the National Academy of Sciences.

[54]  C. Stefanadis,et al.  The role of nitric oxide on endothelial function. , 2012, Current vascular pharmacology.

[55]  R. Touyz,et al.  Reactive oxygen species and endothelial function--role of nitric oxide synthase uncoupling and Nox family nicotinamide adenine dinucleotide phosphate oxidases. , 2012, Basic & clinical pharmacology & toxicology.

[56]  L. Køber,et al.  Endothelial function is unaffected by changing between carvedilol and metoprolol in patients with heart failure-a randomized study , 2011, Cardiovascular diabetology.

[57]  A. Hale,et al.  Rapid, Direct Effects of Statin Treatment on Arterial Redox State and Nitric Oxide Bioavailability in Human Atherosclerosis via Tetrahydrobiopterin-Mediated Endothelial Nitric Oxide Synthase Coupling , 2011, Circulation.

[58]  D. Levy,et al.  Relation of Brachial and Digital Measures of Vascular Function in the Community: The Framingham Heart Study , 2011, Hypertension.

[59]  G. Schuler,et al.  High-dose rosuvastatin in chronic heart failure promotes vasculogenesis, corrects endothelial function, and improves cardiac remodeling--results from a randomized, double-blind, and placebo-controlled study. , 2011, International journal of cardiology.

[60]  Amir Lerman,et al.  Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction. , 2010, Journal of the American College of Cardiology.

[61]  J. Hare,et al.  Impaired S-Nitrosylation of the Ryanodine Receptor Caused by Xanthine Oxidase Activity Contributes to Calcium Leak in Heart Failure* , 2010, The Journal of Biological Chemistry.

[62]  G. Schuler,et al.  Exercise Training in Patients With Advanced Chronic Heart Failure (NYHA IIIb) Promotes Restoration of Peripheral Vasomotor Function, Induction of Endogenous Regeneration, and Improvement of Left Ventricular Function , 2010, Circulation. Heart failure.

[63]  D. Newby,et al.  Understanding the role of endothelial progenitor cells in percutaneous coronary intervention. , 2010, Journal of the American College of Cardiology.

[64]  David M. Herrington,et al.  Predictive Value of Brachial Flow-Mediated Dilation for Incident Cardiovascular Events in a Population-Based Study: The Multi-Ethnic Study of Atherosclerosis , 2009, Circulation.

[65]  A. Quyyumi,et al.  Impact of spironolactone on endothelial function in patients with single ventricle heart. , 2009, Congenital heart disease.

[66]  Susan Anderson,et al.  Irbesartan in patients with heart failure and preserved ejection fraction. , 2008, The New England journal of medicine.

[67]  T. Imaizumi,et al.  Inhibitors of advanced glycation end products (AGEs): potential utility for the treatment of cardiovascular disease. , 2008, Cardiovascular therapeutics.

[68]  Xueli Yuan,et al.  Endothelial-to-mesenchymal transition contributes to cardiac fibrosis , 2007, Nature Medicine.

[69]  G. Keren,et al.  Circulating endothelial progenitor cells and clinical outcome in patients with congestive heart failure , 2007, Heart.

[70]  K. Hirata,et al.  Endothelial nitric oxide synthase uncoupling: Is it a physiological mechanism of endothelium-dependent relaxation in cerebral artery? , 2007, Cardiovascular research.

[71]  L. Liaudet,et al.  Nitric oxide and peroxynitrite in health and disease. , 2007, Physiological reviews.

[72]  N. Freemantle,et al.  FASTTRACK : The perindopril in elderly people with chronic heart failure (PEP-CHF) study , 2006 .

[73]  H. Miller,et al.  Comparative analysis of methods for assessment of circulating endothelial progenitor cells. , 2006, Tissue engineering.

[74]  N. Freemantle,et al.  Perindopril for elderly people with chronic heart failure: the PEP‐CHF study , 1999, European heart journal.

[75]  A. Hoes,et al.  Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. , 2005, European heart journal.

[76]  J. Hare.  Nitroso-redox balance in the cardiovascular system. , 2004, The New England journal of medicine.

[77]  T. Finkel,et al.  Endothelial progenitor cells and endothelial dysfunction , 2004, Vox sanguinis.

[78]  Karl Swedberg,et al.  Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial , 2003, The Lancet.

[79]  J. Hare.  Nitric oxide and excitation-contraction coupling. , 2003, Journal of molecular and cellular cardiology.

[80]  Ayan R Patel,et al.  Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude. , 2003, American heart journal.

[81]  Michael T. Watkins,et al.  Predictive value of noninvasivelydetermined endothelial dysfunction for long-term cardiovascular events inpatients with peripheral vascular disease , 2003 .

[82]  Arshed A. Quyyumi,et al.  Circulating Endothelial Progenitor Cells, Vascular Function, and Cardiovascular Risk , 2003 .

[83]  M. Watkins,et al.  Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. , 2003, Journal of the American College of Cardiology.

[84]  K. Prasad,et al.  Mechanism of superoxide anion-induced modulation of vascular tone , 2011 .

[85]  Joao A. C. Lima,et al.  Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms , 2002, Nature.

[86]  W. Dröge.  Free radicals in the physiological control of cell function. , 2002, Physiological reviews.

[87]  D. Harrison,et al.  Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. , 2000, Circulation research.

[88]  A M Zeiher,et al.  Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. , 2000, Circulation.

[89]  C. Baird,et al.  The pilot study. , 2000, Orthopedic nursing.

[90]  L. Klein,et al.  Simultaneous intracoronary ultrasound and Doppler flow studies distinguish flow‐mediated from receptor‐mediated endothelial responses , 1999, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[91]  I. Fridovich.  Superoxide Anion Radical (O·̄2), Superoxide Dismutases, and Related Matters* , 1997, The Journal of Biological Chemistry.

[92]  J. Loscalzo,et al.  Inhibition of nitric oxide synthase augments myocardial contractile responses to beta-adrenergic stimulation. , 1996, The American journal of physiology.

[93]  A. Yeung,et al.  Close relation of endothelial function in the human coronary and peripheral circulations. , 1995, Journal of the American College of Cardiology.

[94]  M. Creager,et al.  Nitric Oxide Inhibits the Positive Inotropic Response to β-Adrenergic Stimulation in Humans With Left Ventricular Dysfunction , 1995 .

[95]  J. K. Lloyd,et al.  Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis , 1992, The Lancet.

[96]  H. M. Payne,et al.  Validation of A Doppler Guide Wire for Intravascular Measurement of Coronary Artery Flow Velocity , 1992, Circulation.

[97]  P. Ganz,et al.  Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. , 1986, The New England journal of medicine.